| |
| |
|
| Insider
Information: |
Lapuerta Pablo |
| Relationship: |
EVP and CMO |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
85,719 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$135,436 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
85,719 |
|
|
| Total
Value |
$135,436 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
EVP and CMO |
2020-04-22 |
85,719 |
2013-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2020-04-22 |
4 |
D |
$1.96 |
$13,353 |
D/D |
(6,813) |
85,719 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2020-04-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,893 |
92,532 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2020-02-28 |
4 |
D |
$2.77 |
$36,855 |
D/D |
(13,305) |
72,639 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,846 |
85,944 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2019-02-28 |
4 |
D |
$5.51 |
$37,518 |
D/D |
(6,809) |
47,098 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2019-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,932 |
53,907 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2018-02-28 |
4 |
D |
$8.53 |
$41,132 |
D/D |
(4,822) |
33,975 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2018-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,184 |
38,797 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2017-02-28 |
4 |
D |
$16.45 |
$86,395 |
D/D |
(5,252) |
24,613 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2017-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,099 |
29,865 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2016-02-29 |
4 |
D |
$9.07 |
$39,518 |
D/D |
(4,357) |
15,766 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2016-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,728 |
20,123 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2015-03-02 |
4 |
D |
$0.94 |
$17,170 |
D/D |
(18,266) |
58,767 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP and CMO |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,250 |
77,033 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Clin Dev and CMO |
• • – |
2014-02-28 |
4 |
D |
$1.92 |
$23,025 |
D/D |
(11,992) |
26,783 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Clin Dev and CMO |
• • – |
2014-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,500 |
38,775 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Clin Dev and CMO |
• • – |
2013-02-28 |
4 |
D |
$1.98 |
$9,356 |
D/D |
(4,725) |
8,275 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
EVP, Clin Dev and CMO |
• • – |
2013-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,000 |
13,000 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
